
Our Experience list is sortable by client, brand name, (127) USAN/INN name, and therapeutic category:
Sort Clients By: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z || ALL
|
|
|
|
| OBAGI MEDICAL | CLENZIDERM M.D. | Personal Product | | OBAGI MEDICAL | SOLUCLENZ | Dermatology | | ODYSSEY PHARMACEUTICALS | SANCTURA * | Urology | | OLIVER-TOLAS HEALTHCARE PACKAGING | OLIVER-TOLAS HEALTHCARE PACKAGING | Corporate ID | | OMRIX BIOPHARMACEUTICALS | EVICEL | Fibrin Sealant | | ONCOLOGY THERAPEUTICS NETWORK | OTN - ONCOLOGY THERAPEUTICS NETWORK | Corporate ID | | ONCOTHERAPY SCIENCE | ELPAMOTIDE | Oncology | | ORTHO-MCNEIL PHARMACEUTICAL | DURAGESIC | Pain & Inflammation | | ORTHO-MCNEIL PHARMACEUTICAL | PANCREAZE | Immunology | | ORTHO-MCNEIL PHARMACEUTICAL | RAZADYNE | Neurology | | ORTHO-MCNEIL PHARMACEUTICAL | RAZADYNE ER | Neurology | | ORTHO-MCNEIL PHARMACEUTICAL | TOPAMAX | Neurology | | OSI PHARMACEUTICALS | TARCEVA * | Oncology | | OSMOTICA PHARMACEUTICAL | VENALTA | Product ID | | OTSUKA PHARMACEUTICAL | TOLVAPTAN | Identity Research | | OVATION PHARMACEUTICALS | SABRIL * | Neurology | | OXIGENE | FOSBRETABULIN | Oncology | | OXIGENE | FOSBRETABULIN DISODIUM | Oncology | | OXIGENE | FOSBRETABULIN TROMETHAMINE | Oncology |
* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMEA, and/or Health Canada, and other Regulatory Agencies. |
|